Filing Details

Accession Number:
0001104659-10-017667
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-31 13:00:00
Reporting Period:
2010-03-29
Filing Date:
2010-03-31
Accepted Time:
2010-03-31 15:05:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
907654 Arca Biopharma Inc. ABIO In Vitro & In Vivo Diagnostic Substances (2835) 363855489
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1030575 Francois Jean Formela C/O Atlas Venture
890 Winter Street, Suite 320
Waltham MA 02451
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-03-29 140,000 $7.56 1,337,612 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Footnotes
  1. Represents 1,262,163 shares of Common Stock and 75,449 warrants to purchase shares of Common Stock of Arca held by Atlas Venture Fund VII, L.P., or AV VII. These shares are held directly by AV VII. Atlas Venture Associates VII, L.P., or AVA VII LP, is the sole general partner of AV VII. Mr. Formela is a partner with Atlas Venture and one of Arca's directors. Each of Atlas VII, AVA VII LP and Mr. Formela disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein.